{
    "clinical_study": {
        "@rank": "110853", 
        "arm_group": [
            {
                "arm_group_label": "transcranial direct current stimulation", 
                "arm_group_type": "Experimental", 
                "description": "Anodal stimulation on motor cortex"
            }, 
            {
                "arm_group_label": "Sham transcranial direct current stimulation", 
                "arm_group_type": "Sham Comparator", 
                "description": "Turn off after 10 s of stimulation"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the analgesic effect of transcranial direct current\n      stimulation (tDCS) applied on motor cortex in patients with spinal cord injury who have\n      chronic neuropathic pain."
        }, 
        "brief_title": "The Effects of Transcranial Direct Current Stimulation on Central Pain in Patients With Spinal Cord Injury", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Neuropathic Pain", 
            "Spinal Cord Injury"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neuralgia", 
                "Spinal Cord Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "-  anodal stimulation of the primary motor cortex (M1)\n\n        -  anode electrode: C3 (EEG 10/20 system)\n\n        -  cathode electrode: contralateral supraorbital area\n\n        -  constant current of 2mA intensity for 20 min\n\n        -  twice a day with a more than 4 hours interval during of 2 weeks (from Monday to Friday,\n           total 20 treatment session)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  elapsed time since spinal cord injury more than 6 months\n\n          -  stable chronic pain for at least 3 preceding months\n\n          -  pain that was not attributable to cause other that neuropathic pain\n\n          -  pain that was resistant to various types of medications or physical or complementary\n             medicine treatment\n\n        Exclusion Criteria:\n\n          -  any kind of metal implant in the head\n\n          -  heart disease including having a cardiac maker\n\n          -  family or personal history of epilepsy, or neuropsychiatric illness"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01781065", 
            "org_study_id": "11-2008-010 SNUBH"
        }, 
        "intervention": {
            "arm_group_label": [
                "transcranial direct current stimulation", 
                "Sham transcranial direct current stimulation"
            ], 
            "intervention_name": "transcranial direct current stimulation", 
            "intervention_type": "Device", 
            "other_name": "Iomed Phoresor II Auto"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 12, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seongnam-si", 
                    "country": "Korea, Republic of", 
                    "state": "Gyeonggi-do", 
                    "zip": "463-802"
                }, 
                "name": "Seoul National University Bundang Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Analgesic Effect of Transcranial Direct Current Stimulation Over the Primary Motor Cortex on Central Neuropathic Pain Patients With Spinal Cord Injury", 
        "other_outcome": {
            "measure": "Pain interference in general daily life, mood and sleep", 
            "safety_issue": "No", 
            "time_frame": "before the first tDCS session, and 1, 2, 4, 6, 8 wk after start of the stimulation"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University Bundang Hospital", 
            "last_name": "Hyung Ik Shin", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "February 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Numeric rating scale for average pain over the preceding 24h", 
            "safety_issue": "No", 
            "time_frame": "before the first tDCS session, and 1, 2, 4, 6 and 8 wk after the start of the stimulation"
        }, 
        "reference": {
            "PMID": "16564618", 
            "citation": "Fregni F, Boggio PS, Lima MC, Ferreira MJ, Wagner T, Rigonatti SP, Castro AW, Souza DR, Riberto M, Freedman SD, Nitsche MA, Pascual-Leone A. A sham-controlled, phase II trial of transcranial direct current stimulation for the treatment of central pain in traumatic spinal cord injury. Pain. 2006 May;122(1-2):197-209. Epub 2006 Mar 27."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01781065"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Bundang Hospital", 
            "investigator_full_name": "Hyung-Ik Shin", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Patient global impression of change for pain", 
            "safety_issue": "No", 
            "time_frame": "before the first tDCS session, and 1, 2, 4, 6, and 8 wk after the start of the stimulation"
        }, 
        "source": "Seoul National University Bundang Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Bundang Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2008", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}